|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 13TH STREET, N.W. |
Address2 | SUITE 430 NORTH |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 305932-1004912
|
||||||||
|
6. House ID# 380880047
|
TYPE OF REPORT | 8. Year | 2010 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Thomas J. "T.J." Petrizzo, Chairman & CEO |
Date | 07/17/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
As the Pediatric Neuroscience Institute at the Arnold Palmer Hospital for Children continues to align the services provided with the needs of the Central Florida community, this capability was identified as one that could dramatically improve the quality of life of children in the area. To eliminate wait times of 8-10 weeks and provide more advanced imaging services to patients, we are seeking funding to purchase a 3 Tesla MRI, which has substantially greater diagnostic capabilities than the current unit and would
benefit all of the key service that support patients.
Orlando Healths Childrens Advocacy Center program. Advocate for federal funding that will ensure that the thousands of families that experience child abuse each year in Orange County, Florida are able to access the services needed to help them recover and heal. Funding will be used to sustain existing child advocates and therapists, and other costs, as well as expand the programs capacity to provide services, with the addition of two child advocates and four therapists. This will expand access to vital rehabilitation and recovery services for victims of child abuse.
Orlando Healths M.D. Anderson Cancer Center Nano-medicine for Radiation Protection of U.S. Armed Forces. Advocate for federal funding to support a drug discovery program to improve the survival of, provide faster recovery for, and limit or eliminate drug side effects experienced by US military men and women after exposure to high levels of radiation. The funding will be used to create a platform where scientists can study the effect of radiation on nanoparticles with or without cells. Specifically, scientists will identify the form of nanoceria that provides the most effective level of radioprotection. This research will ultimately lead to the development of an effective drug for the treatment of radiation exposure for military personnel who are exposed to high doses of radiation during service to our country. This will be the first feasibility study of the effect of nano-medicine for radioprotection. The requested fudning will finance research on radioprotection for soldiers, and ultimately civilians, who must undergo radiation therapies for illnesses.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
T.J. |
Petrizzo |
|
|
|
Tricia |
Barrentine Guay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
As the Pediatric Neuroscience Institute at the Arnold Palmer Hospital for Children continues to align the services provided with the needs of the Central Florida community, this capability was identified as one that could dramatically improve the quality of life of children in the area. To eliminate wait times of 8-10 weeks and provide more advanced imaging services to patients, we are seeking funding to purchase a 3 Tesla MRI, which has substantially greater diagnostic capabilities than the current unit and would
benefit all of the key service that support patients.
Orlando Healths Childrens Advocacy Center program. Advocate for federal funding that will ensure that the thousands of families that experience child abuse each year in Orange County, Florida are able to access the services needed to help them recover and heal. Funding will be used to sustain existing child advocates and therapists, and other costs, as well as expand the programs capacity to provide services, with the addition of two child advocates and four therapists. This will expand access to vital rehabilitation and recovery services for victims of child abuse.
Orlando Healths M.D. Anderson Cancer Center Nano-medicine for Radiation Protection of U.S. Armed Forces. Advocate for federal funding to support a drug discovery program to improve the survival of, provide faster recovery for, and limit or eliminate drug side effects experienced by US military men and women after exposure to high levels of radiation. The funding will be used to create a platform where scientists can study the effect of radiation on nanoparticles with or without cells. Specifically, scientists will identify the form of nanoceria that provides the most effective level of radioprotection. This research will ultimately lead to the development of an effective drug for the treatment of radiation exposure for military personnel who are exposed to high doses of radiation during service to our country. This will be the first feasibility study of the effect of nano-medicine for radioprotection. The requested fudning will finance research on radioprotection for soldiers, and ultimately civilians, who must undergo radiation therapies for illnesses.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
T.J. |
Petrizzo |
|
|
|
Tricia |
Barrentine Guay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Oppose provision in HR 3962 prohibiting hospitals from submitting separate Medicare reimbursement claims for inpatient care and outpatient care provided within three days of a hospital admission. Support extension of FMAP program. Support extension of 340B.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
T.J. |
Petrizzo |
|
|
|
Tricia |
Barrentine Guay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |